Start: 10 Nov 2021, 16:45
End: 10 Nov 2021, 17:30

Chair: Dr Alastair Greystoke, Newcastle University, UK
Speaker: Dr Carles Escriu, The Clatterbridge Cancer Centre NHS Foundation Trust, UK

The focus of this session will be around the importance of testing for actionable biomarkers within oncology, including how such testing can be accessed via local Genomic Laboratory Hubs. There will also be presentation and discussion around the use of precision medicine once key biomarkers have been identified.

This session is organised and fully funded by Bayer.

Session labels: